Claret Asset Management’s Globus Medical GMED Stock Holding History

Claret Asset Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$212K	Sell	2,688 -1,219	-31%	-$104K	0.02%	489
2026 Q1	$337K	Buy	3,907 +1	+0%	+$90	0.04%	162
2025 Q4	$341K	Sell	3,906 -9	-0.2%	-$683	0.04%	150
2025 Q3	$224K	Sell	3,915 -55	-1%	-$3.17K	0.03%	342
2025 Q2	$234K	Buy	3,970 +965	+32%	+$62.3K	0.03%	275
2025 Q1	$220K	Buy	3,005 +2	+0.1%	+$165	0.03%	240
2024 Q4	$248K	Buy	3,003 +20	+0.7%	+$1.58K	0.04%	174
2024 Q3	$213K	Buy	2,983 +16	+0.5%	+$1.13K	0.03%	284
2024 Q2	$203K	Buy	+2,967	New	+$177K	0.04%	200

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Claret Asset Management's GMED Position: Q2 2026 in Review

Claret Asset Management reduced its Globus Medical (GMED) stake by 31% in Q2 2026, selling an estimated $104K and leaving 2,688 shares worth $212K. The position accounts for 0.02% of the portfolio, ranked #489.

Claret Asset Management first reported a position in GMED in Q2 2024 and has held it in 9 quarters since. The position peaked at $341K in Q4 2025. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Claret Asset Management held 2,688 shares of Globus Medical worth $212K as of Q2 2026.
Claret Asset Management sold 1,219 Globus Medical shares in Q2 2026, an estimated $104K.
Globus Medical made up 0.02% of Claret Asset Management's portfolio in Q2 2026, its #489 holding.
Claret Asset Management first reported a position in Globus Medical in Q2 2024 and has held it in 9 quarters since.
Claret Asset Management's Globus Medical position peaked at $341K in Q4 2025.
601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Claret Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.